BM&FBovespa First Exchange to Join R3

Brazilian exchange will work with consortium on its shared ledger platform.

brazil-flag2

"We believe that strong collaboration with our customers, regulators and vendors is crucial to futureproof financial and capital markets," said Fabio Dutra, client and business development managing director at BM&FBovespa, in a statement. "Innovation with appropriate regulatory oversight is paramount to making the Brazilian markets even more efficient and reliable. Shared ledger technology may play an important role here."

The Brazilian exchange joins the 60-member group that includes firms on the buy and sell side aiming to create distributed ledger solutions that meet the industry's requirements around identity, privacy, security, scalability, interoperability and integration with legacy systems.

"Distributed and shared ledger technology can transform the way in which FMIs (financial market infrastructures) such as BM&FBovespa issue, record and transfer assets, enabling transactions and reference data to be visible to all relevant parties on the ledger," said David Rutter, CEO of R3, in a statement. "This can cut effort and costs dramatically. We are pleased to welcome BM&FBovespa to our growing network of consortium members in Brazil."

 

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: http://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

The Waters Cooler: ’Tis the Season!

Everyone is burned out and tired and wants to just chillax in the warm watching some Securities and Exchange Commission videos on YouTube. No? Just me?

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here